✦ LIBER ✦

A Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty–Platelet Reactivity for Outcome Validation Effort) Study

✍ Scribed by Fabio Mangiacapra; Giuseppe Patti; Emanuele Barbato; Aaron J. Peace; Elisabetta Ricottini; Vincenzo Vizzi; Laura Gatto; Andrea D'Ambrosio; Bernard De Bruyne; William Wijns; Germano Di Sciascio

Book ID: 119289474
Publisher: American College of Cardiology
Year: 2012
Tongue: English
Weight: 954 KB
Volume: 5
Category: Article
ISSN: 1936-8798
DOI: 10.1016/j.jcin.2012.01.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Point-of-Care Measurement of Clopidogrel

Point-of-Care Measurement of Clopidogrel Responsiveness Predicts Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention: Results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) Study

✍ Giuseppe Patti; Annunziata Nusca; Fabio Mangiacapra; Laura Gatto; Andrea D'Ambro 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 301 KB

Randomized Trial of High Loading Dose of

Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention: Results From the ARMYDA-2 (Antiplatelet therapy for Reduction of Myocardial Damage during Angioplasty) Study

✍ G. Patti; G. Colonna; V. Pasceri; L.L. Pepe; A. Montinaro; G. Di Sciascio 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Outcome Comparison of 600- and 300-mg Lo

Outcome Comparison of 600- and 300-mg Loading Doses of Clopidogrel in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: Results From the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Randomized Study

✍ Giuseppe Patti; György Bárczi; Dejan Orlic; Fabio Mangiacapra; Giuseppe Colonna; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 781 KB

Usefulness of Platelet Response to Clopi

Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study)

✍ Giuseppe Patti; Vincenzo Pasceri; Vincenzo Vizzi; Elisabetta Ricottini; Germano 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 689 KB

Efficacy of Atorvastatin Reload in Patie

Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention: Results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial

✍ Germano Di Sciascio; Giuseppe Patti; Vincenzo Pasceri; Achille Gaspardone; Giuse 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 319 KB

High Versus Standard Clopidogrel Mainten

High Versus Standard Clopidogrel Maintenance Dose After Percutaneous Coronary Intervention and Effects on Platelet Inhibition, Endothelial Function, and Inflammation: Results of the ARMYDA-150 mg (Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty) Randomized Study

✍ Giuseppe Patti; Domenico Grieco; Giordano Dicuonzo; Vincenzo Pasceri; Annunziata 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 757 KB